MEDICAL NEWS
Could Urban Lighting Raise Breast Cancer Risk for Some Women?
4:00 PM EST.
Study found link between ambient light and higher odds in young, smoking females, but more research…
Read article
- High-Cal Foods May Raise Cancer Risk in Women, Even Without Weight Gain
- Alternative Medicine Alone as Cancer Treatment Linked to Lowered Survival
- Can a Blood Test Detect a Range of Cancers Earlier?
- Heart Risks May Rise After Cancer Diagnosis
JOURNAL UPDATE
Radioiodine Therapy for Thyroid Cancer Doesn’t Up Stroke Risk
7:00 PM EST. I-131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke- Worse Survival Seen for Alternative Vs Usual Cancer Rx
- One-Quarter With Early Breast Cancer Strongly Considers CPM
- Moderate, Severe OSA Linked to Elevated Blood Coagulability
MONTHLY JOURNAL SUMMARY
July 2017 Briefing - Hematology & Oncology
August 01, 2017. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Characterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib
Elizabeth M. Swisher, MD.
Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…
Bert Vogelstein explains cancer and the unavoidable replicative mutations
Bert Vogelstein, MD.
Investigators at Johns Hopkins University in Baltimore used complex mathematical modeling to track mutations driving abnormal cell growth for 32 types of cancer. From their calculations, the researchers believe that the bulk of cancers are caused by random DNA copying errors (replicative mutations).…
Bevacizumab for breast cancer: FDA grants a stay of execution
Dr. Alberto De la Guerra.
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
MEDICAL FOCUS
BRCA mutation testing
By Tamer M. Fouad, M.D.The BRCA gene test is used to identify mutations in either one of the two breast cancer susceptibility genes, BRCA1 and BRCA2. Women who have inherited…
DISCUSSION
RE: Aspirin Use as Treatment in Colorectal Cancer: Teaching an Old Dog New Tricks
By Jeffrey A. Gordon, M.D.Thank you for reading my article. Interesting theory. Lots of research is ongoing to figure out the many ways aspirin does it magic.
ANNOUNCEMENTS
Sunday Times - Doctors Lounge Voted top 10 best ‘Ask an expert’ website
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.
